CLINICAL_TRIALS
trial_result
· 2011-10-17
Clinical Trial Update: Study of CP-461 in Patients With Advanced Renal Cell Cancer [Phase 2]
Summary
Phase 2 study of CP-461 in advanced renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Astellas Pharma Inc | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED